JMCC Group Chair & CEO Diane Scott announced today that the company is building a state-of-the-art distribution centre on the Channel Island of Jersey to serve medical cannabis patients in the United Kingdom and business partners in the European Union. The move makes it the first private Canadian medical cannabis company to own its entire plant-to-patient supply chain.
In this interview, Diane Scott, owner-CEO and Chair of JMCC, has based her company on the primary goal of providing the best medical cannabis for patients on a global scale. Scott recently spoke with us about the medical cannabis landscape, the important research her company is involved in, the roles women play in the industry, and more.
Cannabis is usually a recreational drug; some of the people who push cannabis as a medicinal drug overstate its efficacy, claiming that it cures practically everything. “We believe there are significant therapeutic benefits, but we do it a disservice by calling it a wonder drug” says Diane Scott, CEO of the Jamaican Medical Cannabis Collective.
The Centre for Medicinal Cannabis (CMC) today announced the appointment of Diane Scott, Chair and Chief Executive Office of Canadian-headquartered Jamaican Medical Cannabis Corporation, as a Founding Partner of the London-based CMC.
Diane Scott, Chairman and CEO, Jamaican Medical Cannabis Collective | Headquartered in Toronto, with operations in Jamaica: Looking ahead, Scott has her eye on the United Kingdom as a new market. She already is working as an adviser to a group helping to shape the MMJ industry in that country. “We have a very ambitious program,” she said.
